Abstract
Low back pain, triggered by intervertebral disc degeneration (IVDD), is one of the most common causes of disability and financial expenditure worldwide. However, except for surgical interventions, effective medical treatment to prevent the progression of IVDD is lacking. This study aimed to investigate the effects of circKIF18A, a novel circRNA, on IVDD progression and to explore its underlying mechanism in IVDD. In this study, we found that oxidative stress was positively correlated with nucleus pulposus cell (NPC) senescence in IVDD and that circKIF18A was downregulated in IVDD and attenuated senescent phenotypes such as cell cycle arrest and extracellular matrix degradation in NPCs. Mechanistically, circKIF18A competitively suppressed ubiquitin-mediated proteasomal degradation of MCM7, and the protective effects of circKIF18A on NPCs were partially mediated by MCM7 under oxidative stress. Intradiscal injection of adenoviral circKIF18A ameliorated IVDD in a rat model. This study revealed that circKIF18A regulates NPC degeneration by stabilizing MCM7 and identified a novel signaling pathway, the circKIF18A-MCM7 axis, for anti-senescence molecular therapy in IVDD.
Similar content being viewed by others
Introduction
Low back pain, triggered by intervertebral disc degeneration (IVDD), is one of the most common causes of disability and financial expenditure worldwide1. Surgical interventions, including percutaneous endoscopic lumbar discectomy, intervertebral disc fusion, and fixation, are often applied clinically for severe IVDD but are accompanied by many complications, such as recurrence of neurological symptoms and degeneration of adjacent intervertebral discs (IVDs)2,3. Hence, it is essential to explore the mechanism of IVDD and improve the strategy for molecular targeted treatment. As the largest avascular tissue in the body, IVDs consist of the annulus fibrosus (AF), cartilage endplate, and nucleus pulposus (NP). It has been demonstrated that nucleus pulposus cells (NPCs), which are surrounded by extracellular matrix (ECM), play a critical role in regulating IVDD4. To date, different theories, including apoptosis, autophagy, and inflammation, have been proposed to determine the mechanism of IVDD5,6. More importantly, senescence contributes to cell cycle arrest and ECM degradation in NPCs7,8, suggesting that anti-senescence is also a key point in attenuating the progression of IVDD.
With advances in bioinformatics and RNA high-throughput sequencing technology in recent years, circular RNAs (circRNAs), single-stranded covalently closed-loop structures, have attracted attention. The biogenesis of circRNAs is robust, conserved, and tissue- or time-specific, indicating that these molecules might have a significant role in biological processes and cell fate9,10. Emerging evidence demonstrates that circRNAs are associated with various diseases, such as cancer and degenerative diseases11,12. Because of their circular structure, the identification and quantification of circRNAs, as well as the characterization of their biological functions, is challenging, resulting in limited knowledge of circRNAs in diseases.
Senescence, characterized by a state of proliferation arrest with different degenerative phenotypes, has been suggested to be correlated with chronic diseases13. It has been reported that accumulation of senescent NPCs is observed in degenerative IVDs, implying that senescence might play an important role in the process of IVDD14. However, the underlying mechanism of NPC senescence is exceptionally complicated. Thus, identifying critical senescence-related molecular targets in NPCs appears to be important in delaying the progression of IVDD.
The minichromosome maintenance (MCM) complex, composed of six highly conserved MCM proteins, is considered an essential regulator in the step of prereplication complex formation, which melts DNA at the origin and unwinds DNA at replication forks15,16. MCM7 is correlated with tumorigenesis and has been found to be a potential human malignant tumor biomarker17. Recent studies have demonstrated that MCM7 knockdown promotes senescent phenotypes (e.g., cell cycle arrest and senescence-associated morphological changes) in fibroblasts17,18, indicating that MCM7 might also act as a crucial mediator of NPC degeneration.
Here, we demonstrated that oxidative stress was positively correlated with NPC senescence and verified circKIF18A (hsa_circ_0021535) in IVDD. CircKIF18A competitively inhibited UBE3A-mediated proteasomal degradation of MCM7 and subsequently suppressed NPC senescence via the p53-p21 and p16 signaling pathways. In addition, circKIF18A protected NPCs from oxidative stress-induced senescence in a MCM7-dependent manner. This study identified a novel circRNA-RNA-binding protein (RBP) axis in NPC senescence and augmented molecular therapeutic strategies for IVDD.
Materials and methods
Ethics statement
All interventions, treatments, and animal care procedures were performed according to the guidelines of the Ethics Committee of Sir Run Run Shaw Hospital and the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. The collection of human NPs and further experiments involving human NPs were approved by the Sir Run Run Shaw Hospital of Zhejiang University School of Medicine in accordance with the guidelines of the Declaration of Helsinki; all participants provided written informed consent.
Human NPs collection
One hundred human NP tissues from patients who underwent lumbar surgery and had no history of diabetes, hypertension, or smoking were collected for subsequent experiments (Supplementary Table 5). In this study, we divided these tissues into five grades in strict accordance with the Pfirrmann grading scale19. Patients with Pfirrmann grade I and II disc degeneration were selected for the control group, and the patients in the IVDD group were those who would like to accept discectomy and vertebral fusion and had Pfirrmann grade III, IV, or V disc degeneration.
Human NPC isolation and culture
Human NPs were collected and taken to the laboratory as soon as possible. After washing with PBS and cutting into pieces, NPs were digested in 0.2% type II collagenase (Sigma, USA) for 2–3 h at 37 °C. The digested tissues were washed again with PBS and cultured in Dulbecco’s modified Eagle’s medium (Thermo Fisher Scientific, USA) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific) and antibiotics (1% penicillin/streptomycin/amphotericin B) in an incubator with 5% CO2 at 37 °C.
ROS detection assay
A ROS assay kit (S0033S, Beyotime, Shanghai, China) was applied to measure cellular ROS levels according to the instructions. Briefly, after treatment as described above, NPCs were incubated with DCFH-DA solution (10 μM) at 37 °C for 30 min. After washing with basal culture medium three times, images of DCFH-DA staining were acquired using a fluorescence microscope (Carl Zeiss, Jena, Germany).
IVDD model establishment and injection of virus
A total of 27 male SD rats (250–300 g) were randomly divided into three groups (namely, the control group, IVDD group, and IVDD + circKIF18A group; n = 9 rats per group). Following anesthetization with 2% (w/v) pentobarbital (40 mg/kg), the discs (Co7/8) were punctured and injected with 2 μL of adenovirus solution using a 33-gauge needle connected to a microliter syringe (Hamilton, Bonaduz, Switzerland). Rats in the control group underwent only a sham operation, and rats in the IVDD group were injected with empty vector adenovirus. Rats in the IVDD + circKIF18A group were injected with circKIF18A overexpression adenovirus. Two weeks later, rats were sacrificed. The discs were collected, fixed with 4% paraformaldehyde for 72 h, and subsequently decalcified in 10% EDTA. Because needle puncture induced complete NP loss in four IVDD rats, the rest of the IVDD rats (n = 5) were used for immunofluorescence and immunohistochemical analyses.
Fluorescence in situ hybridization (FISH)
The circKIF18A probe was designed and purchased from GenePharma (Shanghai, China). Probe signals were detected with a FISH kit (GenePharma) according to the manufacturer’s instructions, and nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI). Finally, fluorescence images were acquired using a fluorescence microscope (Carl Zeiss, Jena, Germany).
Immunofluorescence
Cells treated with different treatments were incubated with 0.5% Triton X-100 for 1–5 min and were then washed with PBS. The cells were then blocked with 10% goat serum for 15 min at 37 °C and incubated with primary antibodies against MCM7 (A11325, Abclonal, Wuhan, China), p21 (27296-1-AP, Proteintech, Wuhan, China), and p16 (A0262, Abclonal) diluted in PBS overnight at 4 °C. The next day, the cells were incubated with Alexa Fluor 488-conjugated or Alexa Fluor 594-conjugated secondary antibodies (Abcam, MA, USA) and were then stained with DAPI. Finally, images were acquired using a fluorescence microscope (Carl Zeiss, Jena, Germany).
Immunohistochemistry
Endogenous peroxidase activity was blocked with 3% hydrogen peroxide after deparaffinization and rehydration of paraffin sections. The sections were then treated with 0.4% pepsin (Meilunbio, Dalian, Liaoning, China) in 5 mM HCl at 37 °C for 30 min for antigen retrieval. Next, the sections were blocked with 10% goat serum for 30 min at 37 °C, incubated with primary antibodies against aggrecan (13880-1-AP, Proteintech), collagen II (28459-1-AP, Proteintech), MMP-3 (17873-1-AP, Proteintech), and MMP-13 (18165-1-AP, Proteintech) overnight at 4 °C, and finally incubated with an HRP-conjugated secondary antibody and components from a DAB horseradish peroxidase color development kit (Cwbiotech, Beijing, China). The rewashed sections were stained with hematoxylin. Immunohistochemical images were acquired using a light microscope (Nikon, Tokyo, Japan).
Adenovirus construction
The vector pAdtrack-CMV (Hanbio, Shanghai, China) was cut to obtain a purified linearized vector. The full-length circKIF18A fragment was amplified using KOD-Plus-Neo (Toyoko, Osaka, Japan) according to the manufacturer’s instructions. Ligation of the linearized vector and fragments was performed using an HB In-FusionTM kit (Hanbio), and the ligated vector was then transformed into competent DH5α cells. After plasmid amplification, identification, and extraction, the extracted plasmids were transfected with packaging plasmids (pHBAd-BHG) into HEK-293T cells using LipoFiterTM transfection reagent (HanBio). After 72 h of transfection, HEK-293T cells were collected and lysed, and the supernatant of the transfected HEK-293T cells was collected for virus purification using a ViraTrapTM Adenovirus Purification Maxi Kit (Biomiga, Santiago, USA).
Lentivirus construction
The full-length circKIF18A fragment was inserted into the pHBLV-CMV-T2A-PURO vector (Hanbio, Shanghai, China). Full-length circKIF18A, full-length MCM7, fragments of MCM7 (141–719, 1–526, and 1–140 + 527–719), and full-length UBE3A were inserted into the pGMLV-CMV-MCS-EF1-ZsGreen-T2A-Puro vector (Genomeditech, Shanghai, China). The sh-circKIF18A and sh-MCM7 fragments were inserted into the pHBLV-U6-RFP-T2A-Puro vector (Hanbio, Shanghai, China). Gene fragments for overexpression were ligated into the linearized vector using the HB In-Fusion assay kit (Hanbio). Gene fragments for knockdown were ligated into the linearized vector using T4 ligase (Beyotime, Shanghai, China). After amplification, identification, and extraction, the lentiviruses were stored at −20 °C.
Transfection
Packaging and envelope plasmids, including pSPAX2 and pMD2.G, were cotransfected with the viral vectors into HEK-293T cells. After 48 h, the culture medium was filtered using a 0.45 μm filter, 2 μg/mL polybrene was added, and the viruses were subsequently used to transfect NPCs. Plasmid transfection was performed using Lipofectamine 3000 (Life Technologies). All transfections were performed according to the manufacturer’s instructions.
RNA immunoprecipitation (RIP)
RIP assays were performed using a Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore, Billerica, MA, USA). NPCs or HEK-293T cells were transfected with the plasmids described above. An equal volume of a solution containing RIP lysis buffer, protease inhibitor cocktail, and an RNase inhibitor was added to approximately 1 × 107 cells from each sample. The cell lysates were incubated with IgG, an anti-MCM7 antibody, or anti-Myc-coated beads at 4 °C overnight. Proteinase K buffer-treated RNAs were extracted using a RNeasy MinElute Cleanup Kit (Qiagen, Valencia, CA, USA) prior to reverse transcription (Accurate Biology, Hunan, China). The levels of full-length circKIF18A and different fragments of circKIF18A were measured using qRT–PCR.
RNA extraction and quantitative real-time PCR analysis
Total cellular RNA was extracted from the cultured cells using TRIzol reagent (Accurate Biology, Hunan, China). For reverse transcription, total RNA was processed using an Evo M-MLV RT Kit for qRT-PCR (Accurate Biology). For qRT-PCR, cDNA was reverse transcribed from total RNA using a Premix Pro TaqHS qPCR Kit (Accurate Biology) in an ABI 7500 sequencing detection system (Applied Biosystems, Foster City, CA, USA). The relative quantities of full-length circKIF18A, circKIF18A fragments, and mRNAs were normalized to ACTB.
Pulldown assay and mass spectrometry
Biotin-labeled oligonucleotide probes (Supplementary Table 6) targeting the junction site of circKIF18A were synthesized (GenePharma, Shanghai, China). Briefly, using a Biotin RNA Labeling Mix Kit (Roche, Indianapolis, IN, USA) and T7 RNA polymerase (Thermo Fisher Scientific, Massachusetts, USA), biotin-labeled RNA probes for circKIF18A were transcribed in vitro as previously described20. The RNA pulldown assay was performed at room temperature, and the precipitated proteins were detected using mass spectrometry at Shice Bio-tech Co., Ltd (Shanghai, China).
Cell proliferation assay
Cell proliferation was evaluated using a Yefluor 488 EdU Flow Cytometry Assay Kit (40278ES60, Yeasen, Shanghai, China). First, NPCs were treated with prewarmed 1 × EdU solution for 24 h. After fixation with 4% paraformaldehyde, the cells were incubated with 2 mg/ml glycine solution and 0.5% Triton X-100 solution at room temperature. Then, the NPCs were treated with Click-iT solution for 30 min at room temperature. After staining with 1× Hoechst 33342, NPCs were observed with a fluorescence microscope (Carl Zeiss).
Western blot analysis
NPCs were lysed with RIPA lysis buffer (Fudebio, Hangzhou, China) containing PMSF (Fudebio, Hangzhou, China) in an ice bath. After boiling with loading buffer (Fudebio), proteins from the samples were electrophoresed using SDS–PAGE gels at 80 V for 2 h and transferred to 0.22 μm polyvinylidene difluoride (PVDF) membranes (Millipore, MA, USA) at 280 mA for 120 min. The membranes were blocked with 5% skim milk powder in TBST for 2 h at room temperature and incubated with antibodies specific for β-actin (AF5001, Beyotime), MCM7 (A11325, Abclonal, Wuhan, China), p21 (27296-1-AP, Proteintech, Wuhan, China), p16 (A0262, Abclonal), aggrecan (13880-1-AP, Proteintech), collagen II (28459-1-AP, Proteintech), MMP-13 (18165-1-AP, Proteintech), and MMP-3 (17873-1-AP, Proteintech) overnight at 4 °C. The next day, the PVDF membranes were washed with TBST and incubated with an HRP-conjugated secondary antibody (Fudebio). After washing with TBST, bands were detected using a ChemiDoc Touch Imaging System (Bio–Rad, Hercules, CA, USA) with a chemiluminescence kit (Fudebio).
Magnetic resonance imaging methods
IVD signals and structural changes were detected by magnetic resonance imaging on sagittal T2-weighted images using a 1.5-T clinical magnet (Philips, Amsterdam, Netherlands). The parameters for T2-weighted imaging were set according to the methods described in a previous study. Then, the degree of IVDD was evaluated using the Pfirrmann grading system19.
Histological evaluation
After IVD tissues were embedded in paraffin, section (4 μm) was processed with a safranin O-fast green staining kit (Solarbio). For safranin O-fast green staining, histological images were acquired using light microscopy (Nikon, Tokyo, Japan), and the histological scores were determined according to previously described criteria21. Image assessment was conducted by two independent observers.
SA-β-gal assay
After seeding in a six-well plate and washing three times with PBS, NPCs were sequentially fixed with 0.2% glutaraldehyde for 20 min at room temperature, washed twice with PBS, and stained with X-gal staining solution (1 mg/mL X-gal, 40 mM citric acid/sodium phosphate, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 150 mM NaCl, and 2 mM MgCl2) at pH 6.0. Images were randomly acquired with a Nikon microscope, and the percentage of SA-β-gal-positive cells was quantified for statistical analysis.
Statistical analysis
Data are presented as the mean ± standard deviation of at least three independent experiments performed with samples from at least three different donors. Statistical analysis was performed using GraphPad Prism 9.0 (GraphPad Software, La Jolla, CA, USA). The data were analyzed using Student’s t-test for comparisons between two groups and using one-way analysis of variance followed by Tukey’s test for comparisons among different groups (three or more groups). Nonparametric data (MRI-based Pfirrmann grades and histological scores) were analyzed using the Kruskal–Wallis H test. Statistical significance was set at P < 0.05.
Results
Oxidative stress is associated with NPC senescence in IVDD
To determine whether oxidative stress is positively associated with NPC senescence in IVDD, we collected NP samples from patients with different degrees of degeneration, as described previously6. First, representative lumbar magnetic resonance images (MRIs) of patients with different IVDD degrees according to the Pfirrmann grading system were obtained and are presented in Fig. 1a22. After digesting NP tissues to obtain primary human NPCs, we performed quantitative real-time polymerase chain reaction (qRT-PCR) and western blot analyses to evaluate ECM metabolism in NPCs, which showed that the levels of catabolic markers, including MMP-13, MMP-3, ADAMTS-4, and ADAMTS-5, increased, while those of anabolic markers, such as aggrecan, collagen II, and SOX-9, decreased with aggravation of IVDD (Fig. 1b, c). In addition, safranin O staining and alcian blue staining revealed that the proteoglycan content in the grade V group was lower than that in either the grade I or grade III group (Fig. 1d). To investigate the expression of senescence markers in IVDD, we performed immunofluorescence staining and found that p53, p21, and p16 levels were increased in degenerative NPs (Fig. 1e). Emerging evidence has demonstrated that degenerative diseases are involved in oxidative stress accumulation and that in vitro oxidative stimuli induce degenerative phenotypes in NPCs5,6,23. However, there is no study showing the relationship between oxidative stress and senescence in IVDD. We then performed a DCFH-DA staining assay to determine the level of cellular reactive oxygen species (ROS) and found that degenerative NPCs showed higher DCFH-DA fluorescence intensities than those with lower degeneration degrees (Fig. 1f). Collectively, these results indicate that NPC senescence is accompanied by oxidative stress accumulation in IVDD.
CircKIF18A expression is downregulated in NP tissues from IVDD patients
Differential expression profiles of circRNAs in NPCs were obtained from the National Center for Biotechnology Information Gene Expression Omnibus database (GSE67566)24. Among the 2893 circRNAs analyzed using a circRNA microarray, 113 exhibited decreased levels in degenerative NP tissues compared with control tissues in accordance with the criteria of a mean fold change of <−1.5 and a p value of < 0.05 (Fig. 2a, b and Supplementary Table 1). To perform a preliminary search for novel potential biomarkers for IVDD, we performed qRT–PCR to identify the top 20 circRNAs based on the absolute logFC values for the downregulated circRNAs. We found that the expression of hsa_circRNA_100772 (circBase ID: hsa_circ_0021535, also termed circKIF18A) showed the most significant reduction in the IVDD group compared to the control group (Supplementary Fig. 1a). The circKIF18A RT–PCR product was amplified by divergent primers, and the back-splice junction sequence of circKIF18A was validated using Sanger sequencing (Fig. 2c). The qRT–PCR results showed that the level of circKIF18A was negatively associated with the IVDD degree (Fig. 2d). In addition, circKIF18A was detectable in cDNA but not in gDNA of NPCs (Fig. 2e) and was more stable than its linear counterpart in NPCs treated with RNase R or actinomycin D (Fig. 2f, g). Moreover, oxidative stress is a potential indicator of NPC senescence, as shown in Fig. 1; thus, we measured the levels of circKIF18A and ROS in NPCs treated with different concentrations of H2O2. The results of fluorescence in situ hybridization (FISH) and DCFH-DA staining assays showed that circKIF18A expression was decreased and the ROS level was increased in NPCs under H2O2-induced oxidative stress (Fig. 2h, i). Therefore, circKIF18A was identified in NPCs and is negatively correlated with oxidative stress in IVDD.
CircKIF18A regulates senescent phenotypes in NPCs
To explore the role of circKIF18A in NPCs, we performed a CCK-8 assay to examine the viability of NPCs transfected with circKIF18A knockdown or overexpression lentivirus. As shown in Fig. 3a, b, circKIF18A knockdown reduced NPC viability, whereas the viability of circKIF18A-overexpressing NPCs increased. The results of the EdU assay revealed that circKIF18A overexpression enhanced NPC proliferation but circKIF18A knockdown had the opposite effect (Fig. 3c). Previous studies have demonstrated that senescence contributes to cell viability reduction and proliferation inhibition5,6. Next, we performed a β-galactosidase staining assay and found that circKIF18A overexpression decreased the number of SA-β-gal-positive cells, whereas circKIF18A knockdown enhanced NPC senescence (Fig. 3d, e). Homeostasis of ECM metabolism maintains IVD hydrostatic pressure and further supports spinal biomechanical force5,25. To explore the mechanism of circKIF18A in ECM metabolism, we performed western blotting and safranin O staining and found that the levels of ECM anabolic markers (aggrecan and collagen II) increased and that those of ECM catabolic markers (MMP-3 and MMP-13) decreased in circKIF18A-overexpressing NPCs; in contrast, circKIF18A silencing accelerated ECM degradation (Fig. 3f–h). Interestingly, our qRT-PCR results revealed that the mRNA expression of MMP13 and MMP3 was negatively regulated by circKIF18A, although the expression of ACAN and COL2A1 was not affected, indicating that circKIF18A probably increased aggrecan and collagen II protein levels by suppressing catabolic enzyme (MMP-13 and MMP3)-mediated ECM degradation (Fig. 3i, j). Together, these results indicate that circKIF18A suppresses senescence in NPCs by promoting cell proliferation and balancing ECM metabolism.
CircKIF18A increases the MCM7 level by inhibiting its ubiquitination in NPCs
Based on the functions of circKIF18A shown above, we performed a pulldown assay followed by mass spectrometry to examine the potential RBPs binding to circKIF18A and further explored the mechanism underlying the role of circKIF18A in NPCs (Fig. 4a). In analyzing the RNA immunoprecipitation (RIP)-mass spectrometry results, we removed proteins of the negative control probe group from the circKIF18A protein set (Supplementary Fig. 2a and Supplementary Tables 2–4). In the ranking list, the top-ranked protein was MCM7, with a score of 150.66 (Fig. 4b). We then performed qRT–PCR after RIP and found that circKIF18A was enriched by the anti-MCM7 antibody and that circKIF18A overexpression promoted circKIF18A enrichment in NPCs (Fig. 4c), suggesting that circKIF18A interacts with MCM7 in NPCs.
To further investigate the effect of circKIF18A on MCM7, we transfected NPCs with sh-circKIF18A and circKIF18A overexpression lentiviruses to determine the MCM7 protein and mRNA levels. As shown in Fig. 4d, circKIF18A knockdown decreased the MCM7 protein level, which was increased in circKIF18A-overexpressing NPCs. However, the qRT-PCR results showed that circKIF18A overexpression did not significantly change the MCM7 mRNA level, indicating that circKIF18A might regulate MCM7 expression posttranscriptionally (Fig. 4e). Treatment with cycloheximide (CHX), a protein synthesis inhibitor, led to faster degradation of MCM7 in circKIF18A-silenced NPCs than that in vector group (Fig. 4f, g), and circKIF18A overexpression slowed the degradation rate of MCM7 in NPCs (Fig. 4h, i). In addition, immunofluorescence staining showed that MCM7 expression was enhanced by circKIF18A overexpression (Fig. 4j).
It has been reported that MCM7 degradation is involved in the ubiquitin–proteasome pathway26. Based on our results in this study, we presumed that circKIF18A might increase the MCM7 protein level by suppressing its ubiquitin-mediated proteasomal degradation. To investigate this possibility, we treated circKIF18A-silenced NPCs with or without MG132, a proteasome inhibitor, to measure the MCM7 protein level and found that MG132 treatment increased the MCM7 level in circKIF18A-silenced NPCs (Fig. 4k). Additionally, MCM7 was more ubiquitinated in circKIF18A-silenced cells and less ubiquitinated in circKIF18A-overexpressing NPCs (Fig. 4l, m). Together, these data indicate that circKIF18A increases the MCM7 protein level in NPCs by inhibiting its ubiquitin-mediated proteasomal degradation.
CircKIF18A interacts with MCM7 and prohibits its degradation by UBE3A
As shown in Supplementary Fig. 3a–c, we predicted the mutual binding sites in circKIF18A and MCM7 via the catRAPID database (http://service.tartaglialab.com/page/catrapid_group). To identify the region in circKIF18A that interacts with MCM7, a series of circKIF18A truncations were constructed to map circKIF18A regions (Fig. 5a), and the results of RIP showed that the full length and truncation 2 (circ-T2) of circKIF18A were enriched by the anti-MCM7 antibody (Fig. 5b). To investigate the circKIF18A-binding regions in MCM7, three deletion mutation constructs named ND1 (deletion of one N-terminal domain), CD1 (deletion of one C-terminal domain), and MD1 (deletion of the 142-526 amino acid (aa) domain) were constructed (Fig. 5c), and RIP was then performed to evaluate their binding capacity to circKIF18A. Our results showed that only the CD1 construct could not bind to circKIF18A, suggesting that the 527–719 aa region of MCM7 was necessary for its interaction with circKIF18A (Fig. 5d). It has been documented that ubiquitin ligase E3A (UBE3A) can ubiquitinate MCM7 through a specific homotypic motif26. Our western blot analysis results showed that UBE3A knockdown increased the MCM7 level, which was decreased by circKIF18A knockdown in NPCs (Fig. 5e, Supplementary Fig. 4a, b). In addition, the interaction between UBE3A and MCM7 was inhibited by circKIF18A overexpression in a dose-dependent manner (Fig. 5f). Therefore, we hypothesized that circKIF18A might compete with UBE3A to inhibit ubiquitin-mediated proteasomal degradation of MCM7 by disrupting the interaction between UBE3A and MCM7. To verify our hypothesis, we performed RIP and found that circKIF18A interacted with MCM7 but not UBE3A (Fig. 5g). Moreover, the interaction of MCM7 and UBE3A was suppressed by circKIF18A in NPCs (Fig. 5h, i). UBE3A substrates share a UBE3A-binding consensus motif, which is termed the L2G box26. The L2G box, conserved between the MCM7 amino acid sequences of human and rats, is located in the predicted circKIF18A-binding region of MCM7 (Fig. 5j and Supplementary Fig. 3c). Notably, mutation of the L2G box motif abolished the effects of UBE3A and circKIF18A on the exogenous MCM7 protein level, demonstrating that the L2G box motif overlaps with the circKIF18A-binding region (Fig. 5k and Supplementary Fig. 3d). Together, these data indicate that circKIF18A interacts with MCM7 and inhibits the degradation of MCM7 by competing with UBE3A.
MCM7 mediates the effects of circKIF18A on NPC degeneration by regulating senescence under oxidative stress
We next investigated whether MCM7 is necessary for the functions of circKIF18A in NPC degeneration. First, MCM7 knockdown inhibited the high NPC viability mediated by circKIF18A under oxidative stress (Fig. 6a, Supplementary Fig. 5a, b). Then, we performed an EdU assay and found that MCM7 knockdown decreased the proliferative capacity of circKIF18A-overexpressing NPCs treated with H2O2 (Fig. 6b). The results of the SA-β-gal assay showed that the number of SA-β-gal-positive cells was elevated by MCM7 knockdown in circKIF18A-overexpressing NPCs, implying that MCM7 mediates the effects of circKIF18A on NPC senescence under oxidative stress (Fig. 6c, d). Additionally, the percentage of cells in G0/G1 phase was reduced by circKIF18A overexpression, and MCM7 knockdown partially abolished the inhibitory effect of circKIF18A on cell cycle progression under oxidative stress (Fig. 6e, f). Furthermore, circKIF18A overexpression promoted ECM anabolism and prohibited ECM catabolism, whereas MCM7 knockdown partially inhibited the effects of circKIF18A in H2O2-treated NPCs (Fig. 6g). Similar to the results shown in Fig. 3h, i, MCM7 knockdown promoted the mRNA expression of MMP13 and MMP3 but not ACAN and COL2A1 (Fig. 6h). It has been reported that the p53-p21 and p16 pathways are two major pathways involved in NPC senescence27. To explore the specific mechanism of the circKIF18A-MCM7 axis in senescence, we determined the protein levels of p53, p21 and p16 in circKIF18A-overexpressing NPCs with or without MCM7 knockdown. As shown in Fig. 6i, MCM7 knockdown alleviated circKIF18A-induced inhibition of p53, p21, and p16 expression. In addition, we evaluated the proteins downstream of p21 and p16, such as cyclin D1, cyclin-dependent kinase 4 (CDK4), and retinoblastoma protein (RB), and found that MCM7 knockdown downregulated cyclin D1 and CDK4 expression and inhibited RB phosphorylation (Fig. 6j). A previous study demonstrated that p21 activation can occur in either a p53-dependent or p53-independent manner28. In Fig. 6k, the western blot results show that p53 knockdown reduced the p21 level in circKIF18A-silenced NPCs, suggesting that circKIF18A regulates the classical p53-p21 signaling pathway. To evaluate the effect of the circKIF18A-MCM7 axis on the cellular ROS level, we performed DCFH-DA staining and found that the circKIF18A-MCM7 axis showed no predominant effect on the DCFH-DA intensity in NPCs under oxidative stress (Fig. 6l, m), suggesting that the circKIF18A-MCM7 axis alleviates NPC degeneration without affecting the cellular ROS level and that the beneficial role of the circKIF18A-MCM7 axis can be attributed to suppression of senescence-related pathways in NPCs. Thus, these results indicate that circKIF18A prohibits NPC senescence in a MCM7-dependent manner by regulating classical senescence signaling pathways.
CircKIF18A regulates IVDD in a rat puncture-induced IVDD model
Because human circKIF18A contains a homologous interaction region with rat MCM7 according to the catRAPID database (Supplementary Figs. 3a–c and 6a–c), we applied the human circKIF18A overexpression adenovirus in rat models of puncture-induced IVDD as previously described29. First, we successfully overexpressed circKIF18A in rat tail discs (Supplementary Fig. 6d). The results of safranin O and fast green (S&O) staining and alcian blue staining showed that circKIF18A overexpression attenuated structural disc degeneration and increased the proteoglycan content (Fig. 7a, b, d). Additionally, circKIF18A adenovirus injection reduced disc height loss compared with that in the IVDD group (Fig. 7c, e). Next, the question of whether circKIF18A regulates MCM7 expression in rats needed to be addressed. As shown in Supplementary Fig. 6e, injection of circKIF18A overexpression adenovirus increased the reduced MCM7 level in punctured NPs. Next, we performed immunohistochemistry and found that circKIF18A promoted ECM anabolism and inhibited ECM catabolism in degenerative NPs (Fig. 7f). Moreover, our immunofluorescence results showed that overexpression of circKIF18A reduced the p53, p21, and p16 levels in vivo (Fig. 7g–i). Therefore, our data suggest that circKIF18A ameliorates IVDD by increasing the MCM7 level and inhibiting senescence in NPCs.
Discussion
With the development of bioinformatics and genomics techniques, numerous circRNAs have been identified in human diseases, and their functions and molecular mechanisms have been gradually elucidated. Our previous study demonstrated that circTADA2A is able to serve as a competing endogenous RNA to accelerate osteosarcoma development by regulating the c-JUN-mediated signaling pathway and that CircSERPINE2 attenuates osteoarthritis by sponging miR-1271 in chondrocytes11,30. Moreover, circVMA21 and circERCC2 protect NPCs from degeneration by acting as miRNA sponges31,32. CircRNAs, which are highly stable and conserved among species, have diverse regulatory mechanisms due to their specific covalent closed-loop structure. However, except for studies focusing on sponging miRNAs, no study has investigated the novel mechanism of circRNAs in IVDD. Hence, more research is urgently needed to explore the novel role of circRNAs in IVDD and solve the mysteries of IVDD.
Although a number of circRNA functions are still unknown, compelling evidence has shown that circRNAs can interact with RNAs or proteins to affect gene transcription or regulate posttranslational modification by forming complexes in the nucleus or cytoplasm33,34,35. In this study, we found that circKIF18A overexpression increased the protein level of MCM7 by reinforcing its stability. Furthermore, MCM7 acts as a critical regulator of the cell cycle and is well investigated in the field of oncology17,36. A previous study showed that the E3 ubiquitin ligase UBE3A can accelerate MCM7 degradation via ubiquitination26. We demonstrated that circKIF18A suppress ubiquitin-mediated proteasomal degradation of MCM7 by competing with UBE3A and that the UBE3A-binding motif overlaps with the circKIF18A-binding site. Thus, we concluded that circKIF18A interacts with MCM7 and competitively prohibits UBE3A-induced MCM7 degradation.
Cellular senescence is a durable cell cycle arrest induced by stimuli such as irradiation, toxins, and inflammation37. Broadly, the mechanism underlying senescence is considered to involve two classical pathways: the p53-p21 and p16 signaling pathways. To date, MCM7 has been investigated almost solely in cancer, and there is a lack of research on its role in degenerative diseases36,38. In this study, we demonstrated that MCM7 mediates the effects of circKIF18A on NPC senescence and that the circKIF18A-MCM7 axis suppresses senescence via two classical signaling pathways—the p53-p21 and p16 signaling pathways.
Aggrecan and collagen II, two major ECM components in NPs, maintain hydrostatic pressure in discs to promote biomechanical balance, and they are proven to be substrates of matrix metalloproteinases (MMPs), such as MMP-3 and MMP-13, in IVDs39,40. Most studies have shown that changes in the protein levels of aggrecan and collagen II are the same as those in their mRNA levels5. In our study, the circKIF18A-MCM7 axis affected only the protein levels of aggrecan and collagen II and not their mRNA levels, a phenomenon that can be explained by the observation that the circKIF18A-MCM7 axis upregulates the expression levels of these proteins by inhibiting catabolic enzymes (MMP-3 and MMP-13).
This study suggests that NPC senescence is associated with oxidative stress in IVDD and that circKIF18A, as a biomarker of IVDD, alleviates NPC senescence by inhibiting MCM7 degradation and protecting against IVDD. Therefore, our study provides a solid foundation for improving our understanding of IVDD and augments molecular therapeutic approaches for IVDD.
References
Richardson, S. M. et al. Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cells 24, 707–716 (2006).
Chen, C. et al. Autologous fibroblasts induce fibrosis of the nucleus pulposus to maintain the stability of degenerative intervertebral discs. Bone Res. 8, 7 (2020).
He, Y., Liu, C. & Huang, Y. Can bone mineral density affect intra-operative blood loss of mini-invasive posterior lumbar interbody fusion? Laparosc. Endosc. Robot Surg. 3, 66–69 (2020).
Mern, D. S., Beierfuß, A., Thomé, C. & Hegewald, A. A. Enhancing human nucleus pulposus cells for biological treatment approaches of degenerative intervertebral disc diseases: a systematic review. J. Tissue Eng. Regen. Med. 8, 925–936 (2014).
Chen, D. et al. Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo. Cell Death Dis. 7, e2441 (2016).
Wang, J. et al. Small molecule natural compound agonist of SIRT3 as a therapeutic target for the treatment of intervertebral disc degeneration. Exp. Mol. Med. 50, 1–14 (2018).
Novais, E. J., Diekman, B. O., Shapiro, I. M. & Risbud, M. V. p16(Ink4a) deletion in cells of the intervertebral disc affects their matrix homeostasis and senescence associated secretory phenotype without altering onset of senescence. Matrix Biol. 82, 54–70 (2019).
Zhao, Y. et al. Age-related changes in nucleus pulposus mesenchymal stem cells: an in vitro study in rats. Stem Cells Int. 2017, 6761572 (2017).
Kristensen, L. S. et al. The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet. 20, 675–691 (2019).
Lou, J. et al. Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis. Mol. Cancer 19, 138 (2020).
Shen, S. et al. CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Ann. Rheum. Dis. 78, 826–836 (2019).
Yang, Z. et al. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene 38, 2516–2532 (2019).
Childs, B. G., Durik, M., Baker, D. J. & van Deursen, J. M. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat. Med. 21, 1424–1435 (2015).
Roberts, S., Evans, E. H., Kletsas, D., Jaffray, D. C. & Eisenstein, S. M. Senescence in human intervertebral discs. Eur. Spine J. 15, S312–S316 (2006).
Labib, K., Tercero, J. A. & Diffley, J. F. Uninterrupted MCM2-7 function required for DNA replication fork progression. Science 288, 1643–1647 (2000).
Ibarra, A., Schwob, E. & Méndez, J. Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication. Proc. Natl Acad. Sci. USA 105, 8956–8961 (2008).
Ren, B. et al. MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene 25, 1090–1098 (2006).
Avelar, R. A. et al. A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol. 21, 91 (2020).
Pfirrmann, C. W., Metzdorf, A., Zanetti, M., Hodler, J. & Boos, N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine (Philos. Pa 1976). 26, 1873–1878 (2001).
Yang, F. et al. Cis-acting circ-CTNNB1 promotes β-catenin signaling and cancer progression via DDX3-mediated transactivation of YY1. Cancer Res. 79, 557–571 (2019).
Han, B. et al. A simple disc degeneration model induced by percutaneous needle puncture in the rat tail. Spine (Philos. Pa 1976). 33, 1925–1934 (2008).
Urrutia, J. et al. The Pfirrmann classification of lumbar intervertebral disc degeneration: an independent inter- and intra-observer agreement assessment. Eur. Spine J. 25, 2728–2733 (2016).
Luo, J., Mills, K., le Cessie, S., Noordam, R. & van Heemst, D. Ageing, age-related diseases and oxidative stress: What to do next? Ageing Res. Rev. 57, 100982 (2020).
Liu, X. et al. Noncoding RNAs in human intervertebral disc degeneration: an integrated microarray study. Genom. Data. 5, 80–81 (2015).
Emanuel, K. S. et al. Poroelastic behaviour of the degenerating human intervertebral disc: a ten-day study in a loaded disc culture system. Eur. Cell Mater. 29, 330–340 (2015).
Kühne, C. & Banks, L. E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J. Biol. Chem. 273, 34302–34309 (1998).
Jeong, S. W., Lee, J. S. & Kim, K. W. In vitro lifespan and senescence mechanisms of human nucleus pulposus chondrocytes. Spine J. 14, 499–504 (2014).
Kreis, N. N., Louwen, F. & Yuan, J. The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy. Cancers. https://doi.org/10.3390/cancers11091220 (2019).
Guo, W. et al. The circular RNA circ-GRB10 participates in the molecular circuitry inhibiting human intervertebral disc degeneration. Cell Death Dis. 8, 612 (2020).
Wu, Y. et al. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol. Cancer 18, 73 (2019).
Xie, L. et al. CircERCC2 ameliorated intervertebral disc degeneration by regulating mitophagy and apoptosis through miR-182-5p/SIRT1 axis. Cell Death Dis. 10, 751 (2019).
Cheng, X. et al. Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein. Ann. Rheum. Dis. 77, 770–779 (2018).
Shen, S. et al. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol. Cancer 19, 151 (2020).
Li, X., Yang, L. & Chen, L. L. The biogenesis, functions, and challenges of circular RNAs. Mol. Cell. 71, 428–442 (2018).
Xie, M. et al. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation. Mol. Cancer 19, 112 (2020).
Qu, K. et al. MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. Cell Death Dis. 8, e2603 (2017).
Mowla, S. N., Lam, E. W. & Jat, P. S. Cellular senescence and aging: the role of B-MYB. Aging Cell. 13, 773–779 (2014).
Ishimi, Y. Regulation of MCM2-7 function. Genes Genet. Syst. 93, 125–133 (2018).
Wang, W. J. et al. MMPs and ADAMTSs in intervertebral disc degeneration. Clin. Chim. Acta 448, 238–246 (2015).
Setton, L. A. & Chen, J. Mechanobiology of the intervertebral disc and relevance to disc degeneration. J. Bone Jt. Surg. Am. 88, 52–57 (2006).
Acknowledgements
The authors are grateful to Shuanglin Wan for funding assistance. This work was supported by the National Key R&D Program of China [grant number 2018YFC1105202], Key Research and Development Plan of Zhejiang Province [grant number 2018C03060], National Nature Science Fund of China [grant numbers 81972089, 81802680 and 82101647], Key Project of the Provincial Natural Science Foundation [grant number Z20H060003], Zhejiang Provincial Natural Science Foundation of China [grant numbers LQ20H060001 and LQ20H060005], and Zhejiang Xinmiao Talent Program [grant number 2020R401233].
Author information
Authors and Affiliations
Contributions
J.L.W., D.D.X., Y.L., and W.B.X. performed the majority of the experiments and wrote the manuscript. Y.S.W. assisted with western blot analysis and transfection. J.X.C. and J.J.C. assisted with human nucleus pulposus collection and rat model establishment. P.Y.S. and S.J.W. assisted with cell culture and PCR. X.Y.W., L.F.S., and S.W.F. provided clinical support and supervised the project. SW Fan provided the idea, made the experimental plan, revised the manuscript, and will handle correspondence at the postpublication stages. S.Y.S. provided the idea, made the experimental plan, revised the manuscript, and will handle correspondence at all stages of review and publication.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, J., Xia, D., Lin, Y. et al. Oxidative stress-induced circKIF18A downregulation impairs MCM7-mediated anti-senescence in intervertebral disc degeneration. Exp Mol Med 54, 285–297 (2022). https://doi.org/10.1038/s12276-022-00732-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s12276-022-00732-0
- Springer Nature Limited
This article is cited by
-
Noncoding RNAs in skeletal development and disorders
Biological Research (2024)
-
Role of Galectin-3 in intervertebral disc degeneration: an experimental study
BMC Musculoskeletal Disorders (2024)
-
Self-powered triboelectric-responsive microneedles with controllable release of optogenetically engineered extracellular vesicles for intervertebral disc degeneration repair
Nature Communications (2024)
-
Circular RNA KIAA0564 Serves as a Competitive Endogenous RNA for MicroRNA-424-5p, Mediating the Expression of Lysine Demethylase 4a, Thereby Facilitating Intervertebral Disc Degeneration
Applied Biochemistry and Biotechnology (2024)